Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases

(2021) Pablo Garcia‐Pavia et al.   EUROPEAN JOURNAL OF HEART FAILURE

Narrative review of pharmacotherapy for transthyretin cardiac amyloid

(2021) Jose B. Cruz Rodriguez et al.   Annals of Translational Medicine

Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry

(2021) Margaret M. Parker et al.   Scientific Reports

CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis

(2021) Dennis Korthals et al.   Scientific Reports

Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression

(2021) David Adams et al.   Orphanet Journal of Rare Diseases

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy

(2020) David Adams et al.   JOURNAL OF NEUROLOGY

Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care

(2020) Marco Luigetti et al.   Therapeutics and Clinical Risk Management

Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus

(2020) M. Grandis et al.   Orphanet Journal of Rare Diseases

Estimating the prevalence of allelic variants in the transthyretin gene by analysing large-scale sequencing data

(2019) Carmen Lahuerta Pueyo et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations*

(2019) Isabel Conceição et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis

(2019) Thirusha Lane et al.   CIRCULATION

Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease

(2019) David Adams et al.   Nature Reviews Neurology

Estimating the global prevalence of transthyretin familial amyloid polyneuropathy

(2018) Hartmut H. Schmidt et al.   MUSCLE & NERVE

Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm

(2018) Yoshiki Sekijima et al.   Orphanet Journal of Rare Diseases

Analysis of the TTR gene in the investigation of amyloidosis: A 25-year single UK center experience

(2018) Dorota Rowczenio et al.   HUMAN MUTATION

A new staging system for cardiac transthyretin amyloidosis

(2017) Julian D Gillmore et al.   EUROPEAN HEART JOURNAL

Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisCLINICAL PERSPECTIVE

(2016) Julian D. Gillmore et al.   CIRCULATION

Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis

(2016) Laura Obici et al.   CURRENT OPINION IN NEUROLOGY

Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe

(2016) Yesim Parman et al.   CURRENT OPINION IN NEUROLOGY

“Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy

(2016) Isabel Conceição et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy

(2016) Hartmut H.-J. Schmidt et al.   MUSCLE & NERVE

A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK

(2015) A S Carr et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Early Identification of Transthyretin-Related Hereditary Cardiac Amyloidosis∗

(2014) Eloisa Arbustini et al.   JACC-Cardiovascular Imaging

Guideline of transthyretin-related hereditary amyloidosis for clinicians

(2013) Yukio Ando et al.   Orphanet Journal of Rare Diseases

Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective

(2012) C. Rapezzi et al.   EUROPEAN HEART JOURNAL

Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant

(2011) P. T. Sattianayagam et al.   EUROPEAN HEART JOURNAL